Softwr

AI · head to head

Galileo vs LatchBio

Galileo logo

Galileo

AI

Evaluation and observability platform for GenAI applications and agents

From
Free
Rated
-
Full reviewWebsite
LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Rated
-
Full reviewWebsite

The short version

  • Only Galileo has a free tier, so it costs nothing to try first.
  • Each has a real cost: Galileo the free plan is limited to 5,000 traces per month, which is quickly outgrown by production workloads.; LatchBio the company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.
  • They diverge on capability: Galileo covers Pre-built evaluations, LatchBio covers Agent driven analysis.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Galileo and LatchBio actually diverge.

Attributes where Galileo and LatchBio differ
AttributeGalileoLatchBio
Starting priceFreeOn request
Pricing modelfreemiumquote
Free tierYesNo
Platformsweb, apiWeb

Identical on both: user rating (Not yet rated), category (AI).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Galileo

  • Pre-built evaluations
  • Ground truth capture
  • Luna models
  • Agent behavior analysis
  • Production guardrails
  • Flexible deployment

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

What people use each for

The jobs each tool is most often brought in to do.

Galileo

  • Evaluating RAG and agent applications before production releasenot LatchBio
  • Monitoring live GenAI applications for failures and driftnot LatchBio
  • Applying real-time guardrails without custom integration worknot LatchBio
  • Reducing evaluation costs using distilled Luna judge modelsnot LatchBio

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot Galileo
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot Galileo
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot Galileo
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot Galileo

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Galileo

  • The free plan is limited to 5,000 traces per month, which is quickly outgrown by production workloads.
  • Real-time guardrails and unlimited trace capacity are reserved for the custom-priced Enterprise tier.
  • Pro plan pricing scales with trace volume, so costs can grow unpredictably as usage increases.
  • On-premises deployment requires an Enterprise contract rather than being available self-serve.

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output.
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent.
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow.
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing.

Pricing, plan by plan

Galileo

Free
  • FreeFree
    • 5,000 traces/month
    • Unlimited users
    • Unlimited custom evaluations
  • Pro$100/month
    • 50,000 traces/month
    • Standard role-based access control
    • Advanced analytics and insights
  • Enterprise$undefined/mo
    • Unlimited trace capacity
    • Custom rate limits
    • Hosted, VPC, or on-prem deployment

LatchBio

On request
  • LatchBio Platform$undefined/year
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

Which should you pick?

Choose Galileo if

  • You need pre-built evaluations.
  • You want to start without paying.
  • You work on web, api.
  • You also want ground truth capture.
Galileo review

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.
LatchBio review

Questions people ask

Is Galileo or LatchBio better?
Neither clearly leads. Galileo starts at Free and LatchBio at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Galileo or LatchBio?
Galileo has a free tier; the other does not. Paid plans start at Free for Galileo and On request for LatchBio.
Does Galileo or LatchBio run on more platforms?
Galileo runs on web, api. LatchBio runs on Web.
Can I use Galileo for free?
Yes. Galileo has a free tier, so you can try it without paying. LatchBio starts at On request.
What is Galileo best used for?
Galileo is most often used for evaluating rag and agent applications before production release, monitoring live genai applications for failures and drift, applying real-time guardrails without custom integration work, reducing evaluation costs using distilled luna judge models. Of those, evaluating rag and agent applications before production release and monitoring live genai applications for failures and drift are not what LatchBio is typically brought in for.
What can Galileo do that LatchBio cannot?
Galileo covers Pre-built evaluations, Ground truth capture, Luna models, Agent behavior analysis. LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals.

Answered from the vendors’ own pages

Galileo: What does Galileo cost?

Galileo offers a free plan, a Pro plan at $100/month billed yearly (with a 33% annual discount), and a custom-priced Enterprise plan for unlimited trace capacity.

Source
LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

Galileo: Is there a free plan, and what are its limits?

The Free plan includes 5,000 traces per month with unlimited users and unlimited custom evaluations, aimed at developers and small teams experimenting with GenAI.

Source
LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

Galileo: How is usage metered?

Galileo's pricing scales based on the number of traces processed each month, with Free capped at 5,000, Pro at 50,000, and Enterprise offering unlimited trace capacity.

Source
LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

Share

Related pages

More on Galileo

More on LatchBio

Keep looking

Other head to heads